ClinicalTrials.gg
RecruitingNCT06806397Updated Feb 4, 2025

Study of Hemodynamic Markers of Upper Extremity Motor Dysfunction in Stroke Patients Using Functional Near Infrared Spectroscopy (fNIRS)

An observational study in Stroke, Stroke with Hemiparesis and Stroke, Ischemic, sponsored by Skolkovo Institute of Science and Technology. Recruiting at 2 sites in Russian Federation. Open to participants aged 35 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-04.

Primary conditionIschemic StrokeRegistry: StrokeReclassifiedWhy we changed it
Registry
Stroke — the first condition term the registry derived for this study.
ClinicalTrials.gg
Ischemic Stroke
Why
  1. The study's listed conditions name Ischemic Stroke, a narrower term within Stroke.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Skolkovo Institute of Science and Technology · Observational

From the registry’s dates

  • Started Jun 2024; still recruiting 2 years 4 months later.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
40
Ages
35 Years to 70 Years
Sex
All
01

Study summary

The aim of the study was to explore potential pathways for recovery and adaptation of the motor cortex by examining cerebral blood flow characteristics and hemodynamic markers analyzed by functional near-infrared spectroscopy (fNIRS) in patients with hemiparesis after stroke. Participants in the study performed a simple stimulus-response task several times with one healthy and one paralyzed limb at different stages of basic rehabilitation. A group of healthy, age-matched volunteers participated in the same experiment to verify the stroke-related changes. The researchers recorded fNIRS signals, muscle activity using electromyography, and heart activity using electrocardiography.

Read the detailed description

The study included 40 participants, divided into two groups: individuals with a history of stroke-related hemiparesis and a matched healthy control group.Participants were instructed to perform a stimulus-response task designed to assess reaction speed.During the task, they positioned their hands within a designated box equipped with two buttons corresponding to left and right responses. A visual stimulus, presented via LEDs located above the buttons, served as the response target. A flash of a stimulus required participants to respond by extending their fingers to press the corresponding button. If limb paresis prevented a full button press, participants were instructed to form an intention to move and attempt the task to the best of their ability.

Neurophysiological data acquisition. Functional near-infrared spectroscopy (fNIRS) data were acquired using a combined NIRSport 16x16 and NIRSport 8x8 system (NIRx Medizintechnik GmbH, Berlin, Germany).Twenty-four sources and 24 detectors were placed over the sensorimotor area and adjacent regions, forming 76 source-detector pairs to ensure comprehensive cortical coverage. The light sources were activated synchronously, resulting in a sampling rate of 13.56 Hz. In addition, surface electromyography (EMG), electrocardiography (ECG), and scalp electroencephalography (EEG) were recorded using the NVX-36 electroencephalograph (ISS, Zelenograd, Russia). EMG activity was recorded from the extensor digitorum communis muscle of both hands using a bipolar belly-tendon montage. ECG was recorded by 1st standard bipolar montage with electrode placed on both wrists. EEG was recorded with 6 electrodes placed at 'FCC3', 'FCC4', 'CCP3', 'CCP4', 'FCC5', 'A1', 'FCC6', 'A2' according to the standard "10-05" montage. The experimental protocol was completed within two weeks for each participant. There were six sessions (3 at the beginning of rehabilitation and 3 before discharge). Each session lasted a maximum of one hour. Before the experimental session, each patient's motor abilities were tested using the Action Research Arm Test (ARAT) and the Fugl-Meyer Assessment (FMA) scale.

02

Conditions studied

  • Stroke
  • Stroke with Hemiparesis
  • Stroke, Ischemic

Browse trials for

Keywords

  • stroke
  • hemiparesis
  • hemodynamics
  • fNIRS
  • restoration of motor function
  • Neurovascular coupling
03

In context

Ischemic Stroke Reclassified

2,612 studies on the registry are indexed under Ischemic Stroke; 971 are open to participants now.

This study's planned enrollment of 40 is below the median of 300 across 771 observational studies indexed under Ischemic Stroke.

Browse Ischemic Stroke studies →

Lead sponsor

Skolkovo Institute of Science and Technology is the lead sponsor of 7 studies on the registry; 5 are open to participants now.

Compared within Ischemic Stroke, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Stroke. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
35 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients undergoing rehabilitation at the Federal center of brain research and neurotechnologies, FMBA, Moscow, Russia

Eligibility criteria

For Healthy Volunteers:

Inclusion Criteria:

  1. Availability of signed written . 3. Absence of somatic and psychiatric diseases (more details in the exclusion criteria) 4. Ability and willingness to comply with the requirements of this protocol.

Exclusion Criteria:

  1. The presence of superficial injury of head (S00-S09 International Classification of Diseases 10 (ICD-10).
  2. The presence of mental, behavioural disorders (F00-F99 ICD-10).
  3. Drug addiction in the past or at the moment.
  4. The presence of diseases of the nervous system (G00-G99 ICD-10).
  5. . History of intracranial injury (S06 ICD-10) or stroke (I64 ICD-10).
  6. The presence of somatoform disorders (F45 ICD-10).
  7. Any conditions that, in the opinion of the Investigator, meet the exclusion criteria
  8. Presence of electrical and/or metallic implants or stimulants in the body (eg, implanted deep brain stimulation devices, pacemakers, hearing aids and cochlear implants, intracranial metal implants).
  9. Pregnancy
  10. The presence of malignant neoplasms (C00-C97 ICD-10).

For stroke patients:

Inclusion Criteria:

  1. Signed written informed consent.
  2. People after the first acute cerebrovascular accident (CVA), early or late rehabilitation period.
  3. The level of severity of paresis of the upper limb from 3 points to 0 (according to a 6-point neurological scale)
  4. The minimum visual acuity is not lower than 0.2 on the Sivtsev scale.
  5. The ability and willingness of the patient to comply with the requirements of this protocol.
  6. Expressed patient motivation for rehabilitation.

Exclusion Criteria:

  1. Severe cognitive impairment (\<10 points according to the Scale).
  2. Hamilton score above 18 points.
  3. The score on the Rankin scale is above 4 points.
  4. Associated neurological disorders that cause decreased muscle strength or increased muscle tone in the upper limbs (eg, cerebral palsy, brain damage from trauma) or stiffness (eg, Parkinson's disease, contracture).
  5. Late stages of arthritis or limitation of passive range of motion in any of the joints studied in the study due to other reasons.
  6. The absence of a part of the upper limb due to amputation caused by various reasons.
  7. Any medical condition, including mental illness or epilepsy, that may affect the interpretation of study results, study conduct, or patient safety.
  8. Alcohol abuse, medical marijuana use, or recreational drug use in the 12 months prior to Visit 1.
  9. Use of experimental drugs or medical devices within 30 days prior to Visit 1.
  10. Lack of ability to follow study procedures, in the opinion of the investigator.
  11. The severity of the patient's condition according to the neurological or somatic status, which does not allow full rehabilitation.
  12. Severe visual disturbances, minimal visual acuity less than 0.2 Sivtsev visual acuity table.
  13. Unstable angina and/or heart attack within the previous month
  14. Repeated stroke.
  15. Severe unilateral spatial neglect.
  16. Uncontrolled arterial hypertension
  17. Ataxia
  18. All forms of epilepsy
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • Individuals after stroke

    Diagnostic Test: Stimulus response task

  • Healthy volunteers

    Diagnostic Test: Stimulus response task

Interventions

  • Diagnostic testStimulus response task

    Participants were tasked with performing a finger extension exercise that required pressing buttons in response to visual stimuli. In cases where physical movement was not possible, participants were instructed to imagine performing the task while focusing on their fingers.

06

What researchers measure

Primary outcomes

  1. Hemodynamic changes after stroke

    In post-stroke subjects, an increase in blood flow and oxygenation was observed in sensorimotor cortical regions of both hemispheres during movement of the paretic limb. This observation may indicate that the healthy hemisphere contributes to the execution of movement.

    Time frame: 14 days

07

Study locations

1 of 2 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06806397
Lead sponsor
Skolkovo Institute of Science and Technology
Collaborators
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency of Russia
Responsible party
Sponsor
First posted
Feb 4, 2025
Start date
Jun 26, 2024
Primary completion
Jan 20, 2025
Completion
Apr 2025 (estimated)
Last update
Feb 4, 2025

Study contacts

Daria Petrova, PhD
Contact
d.petrova@skoltech.ru
+7 915 420 5113

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion